M1FG
CRMD icon

Mach-1 Financial Group’s CorMedix CRMD Stock Holding History

Mach-1 Financial Group’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,905
Closed -$173K – 185
2025
Q4 		$173K Buy
+14,905
New +$165K 0.04% 294
2025
Q3 		– Sell
-29,661
Closed -$365K – 290
2025
Q2 		$365K Buy
+29,661
New +$327K 0.11% 151

Other funds holding CRMD

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Mach-1 Financial Group's CRMD Position: Q1 2026 in Review

Mach-1 Financial Group sold out of CorMedix (CRMD) in Q1 2026, closing a stake of 14,905 shares — an estimated $173K sold.

Mach-1 Financial Group first reported a position in CRMD in Q2 2025 and held it in 2 quarters. The position peaked at $365K in Q2 2025. 188 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • Mach-1 Financial Group reported no remaining CorMedix position as of Q1 2026 after selling out during the quarter.
  • Mach-1 Financial Group sold 14,905 CorMedix shares in Q1 2026, an estimated $173K.
  • Mach-1 Financial Group first reported a position in CorMedix in Q2 2025 and held it in 2 quarters.
  • Mach-1 Financial Group's CorMedix position peaked at $365K in Q2 2025.
  • 188 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Mach-1 Financial Group's 13F filing for Q1 2026, filed 13 May 2026.